FTO Fundamentals
Freedom to Operate (FTO) is one of the more misunderstood corners of patent intelligence. The terminology is dense and the legal stakes are real, but the underlying idea is straightforward. This page is a plain-English primer, no patent law background assumed.
Beta — FTO reports in GoVeda are in Beta. The concepts on this page are stable, but report features and coverage are still expanding. See the FTO Report page for what’s currently supported.
The one-line definition
In the countries where I plan to make, sell, or import this product, are there any active patents that could block me?
That’s FTO. It doesn’t ask whether your idea is original (that’s a novelty question). It asks whether acting on your idea will run into someone else’s existing patent rights.
A useful analogy: opening a coffee shop in a mall. Before you sign the lease, you ask whether the address is already taken, whether your logo or menu collides with somebody else’s trademark, and whether zoning rules block what you’re planning. An FTO study is the patent equivalent of those questions.
FTO vs. Novelty vs. Landscape
GoVeda offers three report modes, and people regularly mix them up. Quick reference:
| Novelty | FTO | Landscape | |
|---|---|---|---|
| Question | Is my idea new? | Will making/selling it infringe? | What’s everyone doing in this space? |
| Looks at | All historical prior art | Currently enforceable patents | All filings in scope |
| Time scope | Forever (everything published) | Today’s active rights | A defined window |
| Geography | Global | Per-jurisdiction you select | Per scope |
| Risk if wrong | Application rejected | Lawsuit, injunction, damages | Wrong strategic call |
| Best for | ”Should I file?" | "Should I ship?" | "Where should we play?” |
Simplest way to remember: Novelty is offense (can I get a patent?), FTO is defense (can I avoid getting sued?).
A few terms you’ll see
A short glossary of the words that show up in every FTO conversation:
| Term | One-line definition |
|---|---|
| Jurisdiction | A country or region whose patent law applies (US, EP, JP, CN, SG, etc.). Patent rights are territorial: a US patent doesn’t restrict you in Japan. |
| Claim | The legally binding part of a patent. The numbered statements that define what the owner can exclude others from doing. Courts only look at claims. |
| Claim element | One discrete piece of a claim. A claim like “a device comprising a heating chamber connected to a sensor” has three elements. |
| Literal infringement | Your product matches every element of a claim, word-for-word. |
| DOE (Doctrine of Equivalents) | You don’t match a claim word-for-word, but the difference is “substantially the same way, same function, same result”. A judgment call. |
| Prior art | Anything published before a patent’s filing date. Used to attack a patent’s validity (you can sometimes invalidate a patent that blocks you). |
| Patent family | A set of related patents from the same invention, filed in different countries. |
| Patent term | The protection period. Typically 20 years from the first filing date, with country-specific exceptions. |
| Pending application | A patent application that’s been filed but not yet granted. The risk it represents is provisional; claims may change before grant. |
How traditional FTO works
If you ever see an attorney’s FTO bill, this is roughly what you’re paying for. It’s also the rough shape of what a GoVeda FTO report produces, much faster and much cheaper, but the same anatomy.
- Scope. Define the product in technical detail, the target jurisdictions, and the launch date.
- Search. Pull all candidate patents from each jurisdiction’s database. Combine keyword, classification (CPC/IPC), and assignee searches.
- Pre-filter. Drop expired patents, drop PCT applications that never entered your target country, drop obvious off-topic hits.
- Claim chart. For each surviving patent, lay out every claim element side-by-side with the corresponding product feature. This is the core analytical step.
- Risk assessment. Rate each patent (high / medium / low) on infringement risk, validity risk, and enforceability.
- Design-around. For high-risk patents, suggest engineering changes that would step outside the claim.
- Report. Write it all up, with disclaimers.
A traditional FTO from a patent law firm runs 1–3 months and costs in the low-to-mid six figures. GoVeda compresses that into minutes. The trade-off is described below.
Why we never say “infringes”
Read any GoVeda FTO report and you’ll notice the language is always “high risk of infringing” or “likely to infringe”, never the bare “infringes”. This isn’t hedging for its own sake. There are three layered legal reasons:
- Infringement is a court determination. Stating that a product infringes a patent is something only a judge can do. Anyone else giving that conclusion is overstepping.
- The conclusion depends on evidence we don’t have. An FTO report only sees public patent data. Real infringement analysis would also consider supply contracts, manufacturing locations, and exhaustion arguments, none of which we can see.
- Risk-based language is the legal-safe form. It’s what attorneys use, and it leaves room for new facts to change the conclusion.
We enforce this throughout. The report’s findings, summary, and top-of-page disclaimer all use risk language consistently.
What an FTO report covers (and what it doesn’t)
A pragmatic summary. For the full list see the FTO Report page.
Covered
- Up to 51 jurisdictions, including US, EP, CN, JP, SG, KR, DE, GB
- Granted patents and pending applications
- PCT applications still in their national-phase entry window
- EP member-state validity (via INPADOC)
- US Patent Term Adjustment (where USPTO data exists)
- Per-claim element analysis (claim charts) on all retained patents
- Risk ratings (high / medium / low / insignificant) per patent
- Design-around suggestions for high-risk patents
- PDF export with full claim charts and risk assessment
Not covered
- Trade secrets, copyrights, trademarks, trade dress, regulatory exclusivities (FTO is a patent analysis)
- Chemical structure (SMILES) or biological sequence (FASTA) recognition
- Patent term extensions for pharmaceutical marketing approval (PTE / SPC), which are an upstream data gap
- Estoppel / vitiation analysis
- Boolean A+B+C combination searches (vector retrieval works differently)
If you find yourself wishing the report covered one of these, that’s almost always a real limit, not an oversight. The “Not covered” items are usually constrained by underlying data availability or by deliberate scope decisions (often after attorney review).
What you should do with the report
A GoVeda FTO report is a screening tool. It surfaces patents and concerns worth a closer look. It is not a substitute for attorney review.
A reasonable workflow:
- Run the report. Read the executive summary and risk heatmap.
- Drill into the high-risk patents. Read the claim charts.
- For anything that looks like a real risk, hand the report to a patent attorney for verification before you act on it.
- For design-around suggestions, validate technical feasibility with your engineering team.
Disclaimer
GoVeda FTO reports are produced by AI for informational purposes only. They do not constitute legal advice. Final infringement determinations are made by courts, and acting on the report’s findings without attorney review carries legal risk. See the disclaimers shipped at the top of every report for the full list.
Next steps
- FTO Report. How to run a report and what’s in the output.
- Sample Reports. Public examples.
- Reading a Report. How to interpret the output.